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1. Introduction 
The production of monoclonal antibodies by 
hybridoma cells is a powerful technique for analyzing 
the cell surface. Hybridoma cells producing antibodies 
against external determinants are usually identified 
by an indirect binding assay where the monoclonal 
mouse immunoglobulin is first bound to the cell sur- 
face and the number of monoclonal antibodies bound 
is titrated by binding a second radiolabelled anti- 
mouse immunoglobulin antibody [ 1,2]. This proce- 
dure is very simple as whole cells can be centrifuged at 
low speeds. To identify internal determinants the cell 
must be disrupted or made ‘leaky’ so that the whole 
cell can still be used as a target. In this paper I present 
conditions in which membrane proteins can be cov- 
alently coupled to sepharose and used in a simple 
binding assay to identify monoclonal antibodies 
against internal determinants of cell surface proteins. 
The ‘inside’ antibodies were then used to establish 
conditions where whole cells can be permeabilized 
and used directly in a binding assay. Simple screening 
procedures are essential in the identification of rare 
antibodies. Both of these screening procedures may 
be used to identify monoclonal antibodies against 
antigenic determinants which are hidden in the whole 
cell system. 
2. Materials and methods 
2 .I . Cell lines and tissues 
An EB virus transformed cell line (LKT) was 
derived from human peripheral B lymphocytes (M. 
Thomson, Rigshospitalet , Copenhagen). Primary 
human fibroblasts were explanted from ovarian ter- 
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atomas and kindly provided by Dr Sue Povey, Galton 
Lab., London. The mouse myeloma line used for 
fusion was the g-azaguanine non-secreting derivative 
of MOPC21, P3-NSl/l-Ag4-1 [3]. All these cells 
were grown in RPMl 1640 medium supplemented 
with 10% (v/v) fetal calf serum, penicillin (100 U/ml) 
and streptomycin (50 p/ml). Placentae were 
obtained either from term pregnancies or at an earlier 
stage after termination of pregnancy. Foetal rat lung 
fibroblasts were provided by Dr John Holborrow, 
London Hospital. 
2.2. Immunization and cell fusion 
Balb/c mice were immunized with: 
(i) Crude membrane fraction prepared by hypotonic 
cell lysis and differential centrifugation [4]; 
(ii) Purified plasma membrane glycoproteins from 
the lymphoblastoid cell line, Bristol 8 as in [5,6] 
(these mice were immunized by Dr M. J. 
Crumpton, National Institute for Medical 
Research, London); 
(iii) Human adult haemoglobin (Sigma). 
Subcutaneous injection was administered at least 3 
times over 2 months and finally the mice were primed 
for fusion by a tail-vein immunization 5 days before 
fusion. Cell fusion was performed as in [7]. 
2.3. Covalent coupling to Sepharose 
Sepharose 4B (Pharmacia Ltd) was washed several 
times with distilled water and activated with cyano- 
gen bromide as in [8,9]. The activation was carried 
out at pH 10.5 at 15’C and terminated by the addi- 
tion of ice and copious washing with 0.1 M carbonate 
buffer (pH 9 .O). The activated beads were finally 
resuspended in 0.1 M carbonate buffer (pH 9.0), 0.5% 
deoxycholate (sodium salt, Calbiochem Ltd). Appro- 
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priate amounts of the activated Sepharose was added 
to the protein to be coupled in the carbonate-deoxy- 
cholate buffer (CD buffer). The beads were kept in 
suspension by gentle mixing for 24 h. The amount of 
protein coupled was monitored optically. 
2.4. Binding assay 
An aliquot of sepharose with the appropriate 
coupled protein in CD buffer was incubated with an 
equal volume or less of hybridoma cell supernatant 
or purified antibody. This ensures that the detergent 
level does not fall to <0.25%. The incubation was 
performed at room temperature with continuous or 
intermittent mixing. The beads were then washed by 
centrifugation with at least 3-times 6 vol. CD buffer. 
The binding of antibody to the beads was detected 
using iodinated rabbit anti-mouse IgG. The rabbit 
anti-mouse IgG was purified by affinity chromatog- 
raphy against mouse IgG pepsin degraded and the 
fragments separated by gel filtration (a gift of Dr 
A. F. Williams [lo]). The Fab fragments were 
iodinated by the chloramine T procedure to a spec. 
act. -lo7 cpm/yg. 
2.5 . Antisera and antibodies 
Aside from the genesis of monoclonal antibodies 
described here a purified antiHLA monoclonal anti- 
body identified and characterized by Barnstable et al. 
[2] was used as well as the supernatant of cells pro- 
ducing this antibody (W632). Dr Alan Williams kindly 
supplied a monoclonal antibody against a rat cell sur- 
face protein (W3-13) and MS Frances Brodsky a mono- 
clonal antibody against p-2 microglobulin (BB5). 
Rabbit antiserum against calf brain tubulin was 
prepared using tubulin purified by 3 cycles of polym- 
erization [ 1 l] and was a gift from Dr R. A. Badley, 
Unilever Res., Sharnbrook, England. Dr Badley also 
provided rabbit antiserum against chicken gizzard 
desmin prepared as in [ 131 with the proteolysis inhib. 
itors [14]. 
2.6. Immunofiuorescence and electron microscopy 
Fibroblasts were grown on coverslips in RPM1 
medium supplemented with 10% foetal calf serum. 
The cells were fixed in acetone at -20°C for 15 min. 
Washed in PBS and incubated with the appropriate 
antibody in a moist atmosphere for 30 min. Excess 
first antibody was removed by washing in PBS and 
the cells were incubated in fluorescent second anti- 
body. Fluorescenated rabbit antimouse IgG was pur- 
220 
chased from Miles Labs. and fluorescenated sheep 
anti-rabbit IgG from Wellcome. The coverslips were 
mounted in PBS-glycerol (1:9) and viewed in a Leitz 
Ortholux epifluorescent microscope using a X63 
objective. Photographs were taken by exposing Pan 
X film (Kodak) for 1 min. Rabbit skeletal muscle 
fibres were glycerinated and prepared for electron 
microscopy by MS Belinda Bullard as described in 
[ 151. Rabbit skeletal muscle actin and myosin were 
purified by MS Bullard by the procedures in [ 16,171. 
3. Results and discussion 
3 .I . Immobilization of membrane proteins 
Proteins can be immobilized in many different 
ways. One of the most common procedures is cova- 
lent coupling to cyanogen bromide-activated Sepha- 
rose [8,18]. This paper describes conditions where 
membrane proteins may be coupled to Sepharose. 
Deoxycholate was chosen as the detergent to disrupt 
the membrane fragments because of the low micelle 
size and the planar structure of the bile salt [ 191. 
These two factors might be expected to minimize the 
amount of proteins hidden by the detergent molecule 
and unavailable for coupling. The activated Sepharose 
was immediately mixed with the proteins in carbon- 
ate-bicarbonate buffer (pH 9.0), deoxycholate at 1% 
and stirred at 4’C for 18 h. Immediately after binding 
the residual imidocarbonate groups gave very high 
backgrounds, these decline over several days, but can 
be reduced more quickly by incubating the Sepharose 
with 1 M Tris-HCl (pH 8 .O) or 1 M glycine. The 
coupling efficiency in the presence of detergent mem- 
brane proteins or soluble proteins is high. At least 7 
mgmembrane protein can be bound to 1 ml Sepharose. 
The activated Sepharose has a high background in the 
binding assay which is not present before activation 
(table la). This background is independent of the 
coupled protein and may be due to ionic interactions 
with charged groqs formed on activation. These 
interactions are not disrupted by 1.2 M NaCl. The 
possibility that the M, 3 X 1 O6 exclusion limit of 
Sepharose 4B physically traps molecules is ruled out 
by the low background on unactivated Sepharose. 
Table 1 b shows that membrane proteins coupled to 
Sepharose give increased binding of known mono- 
clonal antimembrane antibodies over the haemo- 
globin-Sepharose control. This binding is specific for 
human proteins and as glycolipids will not be coupled 
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excludes antibodies against the carbohydrate of glyco- 
lipids. This binding can be inhibited by preincubating 
the antibody with excess antigen (table lb, 10). The 
kinetics of binding (not presented) show that the 
reaction is complete in <l h with intermittent mixing. 
The sensitivity (fig.1) of this assay is certainly ade- 
quate for monitoring the supernatant medium of 
hybridoma cells but requires a greater absolute amount 
of target protein than the whole cell binding assay. 
Each point shown in fig.1 and table 1 used 30 ~1 
settled bed volume of Sepharose 4B at 1 mg/protein/ 
ml, equiv. 10’ cells. The whole cell binding assay 
requires lo6 cells/point. Thus in the presence of 
detergent membrane proteins may be coupled to 
Sepharose and are a suitable target for monoclonal 
antibodies. 
3 2. Monoclonal antibodies against in temal 
determinants 
Assaying hybridoma cell supernatants with the 
whole cell binding assay only detects antibodies 
against the cell surface. The antibodies are also 
detected by membrane proteins bound to Sepharose 
(fig.2,3,m). Supernatants which are negative in the 
whole cell binding assay may: 
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Fig.1. Binding of pure monoclonal anti-HLA IgG to mem- 
brane proteins coupled to Sepharose. Membrane proteins 
were prepared from human lymphoblastoid cell line by hypo- 
tonic lysis [5] and coupled to Sepharose (1 mg protein/ml 
settled bed vol. (sbv) of Sepharose; 30 ~1 sbv were used for 
each point). The cpm bound to membrane-Sepharose minus 
cpm bound to a negative control, 30 ~1 sbv haemoglobin- 
Sepharose (1 mg/ml) is shown for increasing amounts of pure 
antiNLA in the first incubation. 
Table 1 
Nature of binding 
a. Second antibody: Iodinated rabbit 
anti-mouse Ig cpm bound to 
First antibody Unactivated Human 
Sepharose haemoglobin 
- Sepharose 
1. Culture 
medium 
2. Cell supernatant 
cx HLA-ABC 
3. Pure (Y HLA-ABC 
4. Pure (Y HLA-ABC 
1.2 M NaCl 
512 1865 
411 2439 
856 7551 
825 8078 
750 7259 
524 6331 
670 6752 
339 5604 
b. 
5. Culture 
medium 
6. Monoclonal 
OL rat antigen 
7. Monoclonal 
CY glycolipid 
8. Monoclonal 
OL HLA-ABC 
9. Monoclonal Q& 
microglobulin 
10. Monoclonal (Y& 
Human Human 
haemoglobin membrane protein 
- Sepharose - Sepharose 
4413 3944 
6086 5893 
5304 5671 
9245 16 461 
4450 7178 
4647 4839 
inhibited with 4573 5433 
pure Pz 4729 5524 
(i) Lack antibodies against human membrane pro- 
teins, or 
(ii) Contain antibodies directed against hidden inter- 
nal determinants. 
Membrane proteins bound to Sepharose can distin- 
guish these two classes. The *in fig.2,3 are results of 
binding assays on supernatants which were negative in 
the whole cell binding assay. It is clear that many of 
these supernatants contain antibodies directed against 
hidden antigenic sites not accessible in the whole cell 
assay. The hybridoma cells in fig.3 are derived from 
mice immunized with lectin purified plasma mem- 
brane glycoproteins so these ‘inside antibodies’ are 
very probably directed against the internal cytoplas- 
mic regions of these transmembrane proteins. Because 
of the interest in cytoskeletal association with the 
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Fig.2. The cpm of ‘ZSI-labelled anti-mouse IgG bound to 
membrane Sepharose (30 ~1 sbv) incubated with increasing 
amounts of pure anti-HLA (0); hybridoma supernatants. 
Shown to be positive by the whole cell binding assay (m); 
hybridoma cell supernatants shown to be negative by the 
whole cell binding assay (A). One of the lower group assaying 
at 2 X 10’ counts above background was subsequently shown 
to decorate the microfilament system (see fig.4). The mice 
were immunized with a crude membrane fraction from 
human placenta. 
plasma membrane the putative inside antibodies 
shown in fig.2 were screened by immunofluorescence 
for their cellular location. One of these antibodies 
gave strong staining of microfilament bundles on pri- 
mary human fibroblasts (fig.4). This staining was 
eliminated by cytochalasin B (5 E.cg/ml, 3 h) but unaf- 
fected by colcemid (1 E.cg/ml, 3 h). The staining pat- 
tern can be seen to differ from the microtubule net- 
work stained with rabbit anti-tubulin antiserum. The 
microfilament bundles are thought to contain many 
proteins but myosin and actin may be the major com- 
ponents [20-221. No association was found between 
the anti-microfilament antibody and rabbit striated 
muscle F-actin,acetone denatured actin or precipitated 
myosin. To test the antibody further foetal rat lung 
fibroblasts were stained by indirect immunofluores- 
cence. Antisera from individuals with chronic active 
hepatitis gave clear microfilament bundles but the 
hybridoma supernatant did not. Nor does the hybrid- 
oma supernatant stain glycerinated rabbit striated 
muscle fibres by either electron microscopy or 
immunofluorescence. It appears then that the anti- 
body is specific for the human form of the protein, 
we do not yet know whether the antibody will stain 
human muscle cells. The characterization of the anti- 
microfilament antibody shows quite clearly that anti- 
inside antibodies can be detected by the Sepharose 
assay system. We used this antibody and the anti- 
HLA monoclonal antibody to determine if whole 
cells may be made permeable and used to detect anti- 
inside antibodies. 
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Fig.3. Membrane proteins coupled to Sepharose were used to 
assay the supernatants of a second hybridoma fusion. In this 
case the mice were immunized with the lentil lectin bound 
glycoproteins from a human lymphoblastoid cell line plasma 
membrane preparation. In the absence of a fist antibody 5 X 
lo3 cpm of 12SI-labelled rabbit anti-mouse IgG are bound 
(-). Addition of 2 pg pure anti-HLA IgG/lOO ~I(30 ~1 sbv) 
assay gave >25 X 1 O3 cpm of anti-mouse IgG bound (+). 
Hybridoma supernatants bound intermediate amounts if they 
had been proved positive in the live whole cell binding system 
(m). Negative supernatants in the whole cell assay contained 
many positives by the membrane-Sepharose criterion (a). 
Lymphoblastoid cells fixed with paraformaldehyde 
(I%), glutaraldehyde (0.2%) or acetone (2 vol.) in the 
absence of detergent bound anti-HLA strongly but 
bound little if any anti-microfilament antibody. How- 
ever, if after 5 min fixation in 0.2% glutaraldehyde in 
phosphate-buffered saline (PBS) at 22°C the solution 
was made 1% in Triton X-100 and incubated for a 
further 5 min, after several washes with PBS these 
cells remained intact by phase contrast microscopy 
and did bind anti-microfilament antibody (fig.4). This 
is a simple alternative assay system for anti-inside 
antibodies. The glutaraldehyde-fixed, detergent-treated 
cells have a higher background binding than whole 
live cells which may be due to glutaraldehyde-mediated 
crosslinking of the soluble antibody. However, exten- 
sive treatment of the cells with the reducing agent 
sodium borohydride (0.5 mg/ml) did not reduce this 
background even though this treatment allows 
immunofluorescent analysis of glutaraldehyde-fixed 
cells. It appears that this background is not due to 
covalent interaction with remaining activated groups. 
The detection of anti-microfilament antibody in 
hybridioma cells derived from mice immunized with 
membranes from a lymphoblastoid cell line provides a 
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Fig.4. Indirect immunofluorescence on primary human fibroblasts using monoclonal antimicrofllament antibody in (a-c) and 
rabbit anti-tubulin antiserum in (d). The microfilament bundles in (a,b) are not present in the cytochalasin B treated cell seen in 
(c). The microtubule stained cell (d) is shown for comparison. The fluorescent second antibody obtained through Miles Labs. was 
used at a dilution of 1:50. The monoclonal antibody was diluted 1:2 and the rabbit antiserum 1: 20 with PBS. The magnification 
is 1500 diameters. In the absence of first antibody there was no staining. 
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Fig.5. Detergent-treated cell binding assay. Lymphoblastoid 
human cells fixed in 0.20% glutaraldehyde and treated Triton 
X-100 are leaky and although the background is relatively 
high when;no first antibody is used (1); no spurious binding 
is observed to a monoclonal anti rat antibody (2); a mono- 
clonal antibody against 10 nm filaments (3); and the anti- 
microfilaments (4) binding as strongly as the anti HLA mono- 
clonal antibody (5); (6-8) confirm that other monoclonal 
antibodies which bind strongly to rat cerebellum are negative 
in this assay system. 
tool for investigating the relationship of the cytoskel- 
eton and the membrane. The difference in binding of 
the anti-HLA and anti-microfilament antibodies to 
whole futed cells suggests that the microfilament 
associated antigen is not present on the cell surface. 
This view is supported by the fact that live attached 
fibroblasts are not ‘patched’ by treatment with the 
anti-microfilament antibody. In contrast treatment of 
live cells with anti-HLA repeatedly made every cell a 
mass of aligned fluorescent spots. Patches generated 
by anti-HLA antibody in [21] aligned over stress 
fibres. Fig.5 shows that this monoclonal anti-micro- 
filament antibody and a monoclonal antibody against 
intermediate filaments (identified by C. Barnstable) 
bind to permeabilized lymphoblastoid cells as detected 
with iodinated rabbit anti mouse immunoglobulin. 
This procedure provides a simple test for antibodies 
against internal cellular determinants. 
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